Diagnosis and treatment of juvenile myelomonocytic leukemia.

Conclusion: The PLT count, LDH level, HbF level and choice of treatment plan are important for the evaluation of prognosis for children with JMML. Although there is a lack of consistency in terms of donors but the A-3V scheme is relatively stable, so HSCT should be preferred for children with poor prognostic factors. PMID: 31389303 [PubMed - in process]
Source: Hematology - Category: Hematology Tags: Hematology Source Type: research